Literature DB >> 3258964

Restoration of hearing after removal of cerebellopontine angle meningioma: diagnostic and therapeutic implications.

P K Maurer1, S H Okawara.   

Abstract

A case of cerebellopontine angle meningioma with restoration of hearing from a profoundly deaf state is presented. Meningiomas of the posterior fossa commonly present with decreased or absent hearing and can appear deceptively similar to acoustic neurinomas on radiographic and audiometric testing. Because total restoration of hearing can occur with meningioma, even with significant preoperative deficit, utilization of the translabyrinthine approach is less desirable if any preoperative question as to the diagnosis exists. Any hearing-impaired patient with a cerebellopontine angle mass that is not conclusively thought to represent acoustic neurinoma should be approached by the suboccipital technique to maximize the opportunity for restoration of hearing.

Entities:  

Mesh:

Year:  1988        PMID: 3258964     DOI: 10.1227/00006123-198803000-00023

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery.

Authors:  Michihiro Kohno; Shigeo Sora; Hiroaki Sato; Masanobu Shinogami; Hidehiko Yoneyama
Journal:  Neurosurg Rev       Date:  2014-12-21       Impact factor: 3.042

2.  Cochlear Dysfunction is not Common in Human Meningioma of the Internal Auditory Canal.

Authors:  Lukas D Landegger; Jong D Lee; Fred H Linthicum; Konstantina M Stankovic
Journal:  Otol Neurotol       Date:  2017-12       Impact factor: 2.311

3.  Hearing recovery after surgical resection of non-vestibular schwannoma cerebellopontine angle tumors.

Authors:  Naira Mkrtchyan; Lauranne Alciato; Michel Kalamarides; Daniele Bernardeschi; Olivier Sterkers; Isabelle Bernat; Mustapha Smail; Nadya Pyatigorskaya; Ghizlene Lahlou
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-27       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.